Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05281406
Title Additional Chemotherapy for EGFRm Patients With the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Goethe University
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.